Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Sensitivity and Specificity of Betula Verrucosa Allergen Extract
NCT02527187Phase 2Completed
- Sponsor
- Inmunotek
- Start
- Sep 2015
- Primary completion
- Apr 2016
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of birch pollen allergen extract in birch pollen allergy, sponsored by Inmunotek. Started Sep 2015; status: completed.
02
Drugs
birch pollen allergen extract
03
Conditions
birch pollen allergy
Beyond the preview
Go deeper on NCT02527187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527187.